Zhejiang Hisoar Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Zhejiang Hisoar Pharmaceutical has a total shareholder equity of CN¥5.5B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 20.3%. Its total assets and total liabilities are CN¥7.6B and CN¥2.1B respectively.
Key information
20.3%
Debt to equity ratio
CN¥1.11b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.48b |
| Equity | CN¥5.46b |
| Total liabilities | CN¥2.15b |
| Total assets | CN¥7.61b |
Recent financial health updates
Does Zhejiang Hisoar Pharmaceutical (SZSE:002099) Have A Healthy Balance Sheet?
Aug 30
Zhejiang Hisoar Pharmaceutical (SZSE:002099) Has Debt But No Earnings; Should You Worry?
May 27Recent updates
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Price Is Out Of Tune With Revenues
Sep 27Does Zhejiang Hisoar Pharmaceutical (SZSE:002099) Have A Healthy Balance Sheet?
Aug 30Zhejiang Hisoar Pharmaceutical (SZSE:002099) Has Debt But No Earnings; Should You Worry?
May 27Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Shares Climb 28% But Its Business Is Yet to Catch Up
Mar 03Financial Position Analysis
Short Term Liabilities: 002099's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥2.1B).
Long Term Liabilities: 002099's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥95.3M).
Debt to Equity History and Analysis
Debt Level: 002099 has more cash than its total debt.
Reducing Debt: 002099's debt to equity ratio has increased from 5.8% to 20.3% over the past 5 years.
Debt Coverage: 002099's debt is not well covered by operating cash flow (12%).
Interest Coverage: Insufficient data to determine if 002099's interest payments on its debt are well covered by EBIT.